Welcome to the Psychopharmacology Module
In Module 4, participants will learn about common medications utilized in brain injury populations. The use of
off-label medications will also be reviewed.
Module 4 Objectives
After completing this module, you will have acquired knowledge about:
- Principles of psychopharmacology in elderly with brain injury
- Medications used by diagnostic category
About the Author
Dr. Mel B. Glenn earned his medical degree from New York University (NYU) School of Medicine.
He completed his
internship and residency in physical medicine and rehabilitation (PM&R) and then a fellowship in spinal cord injury
medicine at NYU. In 1982 he joined the faculty of the Dept. of PM&R at Tufts University and the staff of its
affiliates New England Medical Center Hospitals, New England Sinai Hospital (NESH), and Greenery Rehabilitation
Center. He was Director of Rehabilitation Medicine at Greenery's Brain Injury Program, and then Director of the
Brain Injury Program at NESH. From
1993 until 1998, he was Professor and Chairman of the Dept. of Rehabilitation Medicine at Boston University School
of Medicine and Chief of Rehabilitation Medicine at Boston Medical Center, where he was the Project Director of the
New England Regional Spinal Cord Injury Center's Spinal Cord Injury Model Systems grant. In 1998, he joined the
staff of Spaulding Rehabilitation Hospital as Director of Outpatient and Community Brain Injury Rehabilitation. From
2015-2023, he was Chief, Division of Brain Injury Rehabilitation, Dept. of Physical Medicine & Rehabilitation,
Spaulding Rehabilitation Network. He is an Associate Professor of PM&R at Harvard Medical School (HMS). Dr. Glenn
was Project Director of the Spaulding/Partners TBI Model System at HMS, a research grant funded by the National
Institute on Disability and Rehabilitation Research, from 1998 to 2008, and is currently an advisor to this project.
He has been Medical Director of Brain Injury Services in MA for NeuroRestorative since 1991 and in RI since 2017;
and was named National Medical Director for NeuroRestorative in 2019. He has been Medical Director of Community
Rehab Care since 1996. Dr.
Glenn was the editor of the Update on Pharmacology column of Journal of Head Trauma Rehabilitation from 1985 to
2013.
Dr. Glenn current affiliations include: Associate Professor, Dept. of Physical Medicine & Rehabilitation, Harvard
Medical School, Boston, MA; Staff physiatrist, Division of Brain Injury Rehabilitation, Dept. of Physical Medicine &
Rehabilitation, Spaulding Rehabilitation Hospital, Charlestown, MA; National Medical Director, NeuroRestorative;
Medical Director, NeuroRestorative (Massachusetts, Rhode Island); and Medical Director, Community Rehab Care,
Waltham, MA.